Polar Capital Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$39M	Sell	87,500 -37,500	-30%	-$16.7M	0.2%	101
2025 Q1	$60.6M	Sell	125,000 -50,000	-29%	-$24.2M	0.37%	82
2024 Q4	$70.5M	Hold	175,000	–	–	0.39%	69
2024 Q3	$81.4M	Hold	175,000	–	–	0.39%	58
2024 Q2	$82M	Hold	175,000	–	–	0.48%	58
2024 Q1	$73.2M	Hold	175,000	–	–	0.38%	68
2023 Q4	$71.2M	Sell	175,000 -200,000	-53%	-$81.4M	0.44%	64
2023 Q3	$130M	Hold	375,000	–	–	0.97%	20
2023 Q2	$132M	Hold	375,000	–	–	0.67%	23
2023 Q1	$118M	Buy	375,000 +85,000	+29%	+$26.8M	0.77%	28
2022 Q4	$83.7M	Sell	290,000 -280	-0.1%	-$80.9K	0.67%	45
2022 Q3	$84K	Sell	290,280 -10,000	-3%	-$2.9K	0.54%	45
2022 Q2	$84.6K	Hold	300,280	–	–	0.5%	46
2022 Q1	$78.4K	Sell	300,280 -74,720	-20%	-$19.5K	0.35%	65
2021 Q4	$82.4K	Buy	375,000 +75,000	+25%	+$16.5K	0.31%	70
2021 Q3	$54.4K	Hold	300,000	–	–	0.22%	100
2021 Q2	$60.5K	Sell	300,000 -25,000	-8%	-$5.04K	0.26%	89
2021 Q1	$69.8M	Buy	325,000 +50,000	+18%	+$10.7M	0.43%	70
2020 Q4	$65M	Buy	+275,000	New	+$65M	0.39%	73